Atopic Hand and Foot Dermatitis
1 competing product in clinical development for Atopic Hand and Foot Dermatitis.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lebrikizumab + Placebo | Eli Lilly | Phase 3 | Active | 77 |
1 competing product in clinical development for Atopic Hand and Foot Dermatitis.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Lebrikizumab + Placebo | Eli Lilly | Phase 3 | Active | 77 |